Serb Ltd
Registered name: SERB LTD
Part of Charterhouse GP LLP groupSerb Ltd made £20.9m revenue and £2.8m profit in the year to 31 Dec 2025.
Serb Ltd’s revenue fell 8% to £20.9m in the year to 31 Dec 2025, with £2.8m profit. The company is classified under “wholesale of pharmaceutical goods” and is based in Weybridge; we hold 3 years of its filed accounts.
- Status
- Active
- Location
- Weybridge, London
- Age
- 13 yrs · since 2012
- Type
- Private Limited Company
Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Dec 2023 | 31 Dec 2024 | 31 Dec 2025 |
|---|---|---|---|
| Disclosure | Full P&L | Full P&L | Full P&L |
| Profit & loss | |||
| Revenue (turnover) | £20m | £22.6m | £20.9m |
| Cost of sales | −£7.6m | −£6.9m | −£7m |
| Gross profit | £12.4m | £15.6m | £13.9m |
| Operating profit | £3.5m | £8.3m | £5.1m |
| Profit before tax | £2.6m | £7.7m | £3.5m |
| Profit after tax | £2.1m | £6m | £2.8m |
| Profit (best available) | £2.1m | £6m | £2.8m |
| Employees (average) | — | — | — |
| Ratios | |||
| Profit margin | 10.3% | 26.5% | 13.5% |
| Gross margin | 61.9% | 69.3% | 66.5% |
| Growth (year on year) | |||
| Revenue growth | — | ▲12.7% | ▼7.6% |
| Profit growth | — | ▲189.2% | ▼53.2% |
| Balance sheet — indirect signals, not revenue | |||
| Net assets | — | — | — |
| Source | Accounts · bulk data Apr 2025 | Accounts · bulk data Apr 2025 | Accounts · bulk data Apr 2026 |
How the business works
- Profit margin
- 13.5%
- Profit ÷ revenue.
- Gross margin
- 66.5%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- —
- Revenue ÷ average employees.
- Profit per employee
- —
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- —
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- —
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- —
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- —
- Now —
- Cash at bank
- —
- Now —
- Headcount
- —
- Now —
- Deferred income
- —
- Now —
- Fixed assets
- —
- Now —
Group structure
Ownership chain
- Charterhouse GP LLPultimate parent75–100%
- Serb Ltdthis company
Bands show the share of ownership each company holds in the one below it.
Subsidiaries (1)
- Veriton Pharma LimitedFigures not disclosed
Sister companies (15)
- Taurus UK Holdings LimitedRev. £175m · Profit −£33.4m
- Perseus Bidco UK LtdRev. £97.8m · Profit £31.1m
- Arachne Holdco (UK) LimitedRev. £77.7m · Profit −£28.1m
- Carthage Holdco UK LtdFigures not disclosed
- CCP No.9.12 LimitedFigures not disclosed
- Charterhouse Syndications (X) LimitedFigures not disclosed
- Charterhouse Syndications (XI) LimitedFigures not disclosed
- Colonnade Services LimitedFigures not disclosed
- Cone Investments UK LimitedFigures not disclosed
- Labyrinth UK Holdco LimitedFigures not disclosed
- Pavo Topco LimitedFigures not disclosed
- Phi Topco (UK) LimitedFigures not disclosed
- Sagemcom Broadband UK LimitedFigures not disclosed
- Seda Topco (UK) LimitedRev. — · Profit −£41.8k
- Telio UK Holdco LimitedFigures not disclosed
From the Persons with Significant Control register (corporate controllers only).
Similar profitable businesses
- Tsi Health Sciences (Europe) LimitedBury · Wholesale of pharmaceutical goods
- Revenue
- £20.7m
- Profit
- £12k
- Staff
- 8
- Paul Hartmann LimitedPilsworth Road · Wholesale of pharmaceutical goods
- Revenue
- £21.4m
- Profit
- £277k
- Staff
- 81
- Ibsa Pharma LimitedWatford · Wholesale of pharmaceutical goods
- Revenue
- £22.5m
- Profit
- £412k
- Staff
- 49
- Richardson Healthcare LimitedWholesale of pharmaceutical goods
- Revenue
- £19.2m
- Profit
- £2.2m
- Staff
- 16
- Agrihealth (N.i.) LimitedLurgan · Wholesale of pharmaceutical goods
- Revenue
- £22.7m
- Profit
- £1.1m
- Staff
- 60
- Trion Pharma LimitedCoventry · Wholesale of pharmaceutical goods
- Revenue
- £19.2m
- Profit
- £6.2m
- Staff
- 18
Sources
Latest figures from accounts for the year to 31 Dec 2025 (profit £2.8m), from the Companies House accounts bulk data published Apr 2026. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.